RE: Long term investment1 Oct 2024 12:34
This part of the financial is interesting:
'Additionally, the Directors believe the Company is reaching a growth inflection point with a major customer launch to approximately 10,000 patients and 140 new ordering doctors starting in September 2024'. If you add this to the 225 doctors ordering approximately 3 tests in Q4 we could see revenue of over Β£1m in Q4. Yet that doesn't account for when we go to wider international market in coming months. Plus ramp up in US I think they are under balling future years as being conservative